FDA approves lower-cost daily weight loss pill from Eli Lilly
- Postato il 1 aprile 2026
- Di Bing News
- 1 Visualizzazioni
FDA approves lower-cost daily weight loss pill from Eli Lilly
A new daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the FDA approval of Novo Nordisk’s Wegovy pill.